Let's talk medical research

While the primary goal of clinical trials is to help identify potential new treatments that improve people's health and save lives, it's the unfortunate truth that the patient experience is often not prioritized. This discrepancy becomes evident in industry findings, highlighting a substantial disparity between the services patients want from pharmaceutical companies compared to what they ...

The latest episode of Antidote’s quarterly podcast series Talk of the Towne is available now! Talk of the Towne is focused on bridging the gap between clinical discussion and patient centricity, hosted by Antidote’s Senior Clinical Informatics Manager, Dr. Richard Towne, PharmD.

Because Antidote’s key focus is connecting patients to clinical trials, hearing directly from individuals serves as a great reminder of why we do what we do. One patient we’ve had the pleasure of speaking with is Linda VandeVrede, a former high-tech PR executive who shared her story of chronic pain, clinical trials, and personal experience.

Early breast cancer is a specific diagnosis that occurs when cancerous cells have not yet spread from the breast or lymph nodes to other parts of the body. For a recent medical study, a client approached us to recruit patients who had received this diagnosis within the past 5 years to participate in a medical records registry.

Achondroplasia, a term meaning “without cartilage formation,” is a genetic disorder leading to disproportionate short stature. Sometimes called achondroplastic dwarfism or ACH, this condition has few treatment options and no known cure. However, individuals diagnosed with this condition can typically lead fulfilling, healthy lives with proper management.

Successfully randomizing participants into a clinical trial involves more than just recruiting through advertising outreach. Reaching individuals is part of the equation, but the patient enrollment process spans a much longer journey. That’s why Antidote provides comprehensive referral management services. Our full-service model reduces site burden and improves the patient experience, ultimately ...

Though there is less than a month remaining in 2023, there are still several things that can be done to improve an organization’s clinical trial marketing efforts before the end of the year. Not only will these tips help close the year out strong, but they can also set the stage for a more streamlined 2024 and beyond.

At Antidote, matching individuals to clinical trials is our driving force — and one of the key ways we do this is by prioritizing our connection to patients. Understanding the real-world impact of our work allows us to continually improve our processes and approach clinical trial recruiting from a patient-centric perspective.

Chronic spontaneous urticaria, also called chronic idiopathic urticaria, is a type of chronic hives that come and go unexpectedly. These hives persist daily for a minimum of six weeks without a clear cause or trigger. While this condition can affect anyone at any point, women experience it twice as often as men, and it’s most common between the ages of 20 and 40.